Selected research
Market Structure
Global Remdesivir Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Remdesivir market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Remdesivir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Remdesivir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Remdesivir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Remdesivir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Remdesivir include Kelun Pharma, Hunan Warrant Pharmaceutical, Hainan Haiyao, Bright Gene and Gilead Sciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Remdesivir market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Remdesivir and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Remdesivir sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Remdesivir market size, projected growth trends, production technologies, key applications, and end-use industries.
Remdesivir Segment by Company
Kelun Pharma
Hunan Warrant Pharmaceutical
Hainan Haiyao
Bright Gene
Gilead Sciences
Remdesivir Segment by Type
10 mM*1 mL in DMSO
100mg
10mg
50mg
5mg
Remdesivir Segment by Application
Drug Store
Hospital
Clinics
Others
Remdesivir Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Remdesivir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Remdesivir and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Remdesivir.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Remdesivir market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Remdesivir manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Remdesivir in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Remdesivir in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 10 mM*1 mL in DMSO
- 100mg
- 10mg
- 50mg
- 5mg
Applications
- Drug Store
- Hospital
- Clinics
- Others
Companies covered
- Kelun Pharma
- Hunan Warrant Pharmaceutical
- Hainan Haiyao
- Bright Gene
- Gilead Sciences
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Remdesivir Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Remdesivir Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Remdesivir Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Remdesivir Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Remdesivir Market Dynamics
- 2.1 Remdesivir Industry Trends
- 2.2 Remdesivir Industry Drivers
- 2.3 Remdesivir Industry Opportunities and Challenges
- 2.4 Remdesivir Industry Restraints
3 Remdesivir Market by Manufacturers
- 3.1 Global Remdesivir Revenue by Manufacturers (2021-2026)
- 3.2 Global Remdesivir Sales by Manufacturers (2021-2026)
- 3.3 Global Remdesivir Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Remdesivir Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Remdesivir Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Remdesivir Manufacturers, Product Type & Application
- 3.7 Global Remdesivir Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Remdesivir Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Remdesivir Players Market Share by Revenue in 2025
- 3.8.3 2025 Remdesivir Tier 1, Tier 2, and Tier 3
4 Remdesivir Market by Type
- 4.1 Remdesivir Type Introduction
- 4.1.1 10 mM*1 mL in DMSO
- 4.1.2 100mg
- 4.1.3 10mg
- 4.1.4 50mg
- 4.1.5 5mg
- 4.2 Global Remdesivir Sales by Type
- 4.2.1 Global Remdesivir Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Remdesivir Sales by Type (2021-2032)
- 4.2.3 Global Remdesivir Sales Market Share by Type (2021-2032)
- 4.3 Global Remdesivir Revenue by Type
- 4.3.1 Global Remdesivir Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Remdesivir Revenue by Type (2021-2032)
- 4.3.3 Global Remdesivir Revenue Market Share by Type (2021-2032)
5 Remdesivir Market by Application
- 5.1 Remdesivir Application Introduction
- 5.1.1 Drug Store
- 5.1.2 Hospital
- 5.1.3 Clinics
- 5.1.4 Others
- 5.2 Global Remdesivir Sales by Application
- 5.2.1 Global Remdesivir Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Remdesivir Sales by Application (2021-2032)
- 5.2.3 Global Remdesivir Sales Market Share by Application (2021-2032)
- 5.3 Global Remdesivir Revenue by Application
- 5.3.1 Global Remdesivir Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Remdesivir Revenue by Application (2021-2032)
- 5.3.3 Global Remdesivir Revenue Market Share by Application (2021-2032)
6 Global Remdesivir Sales by Region
- 6.1 Global Remdesivir Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Remdesivir Sales by Region (2021-2032)
- 6.2.1 Global Remdesivir Sales by Region (2021-2026)
- 6.2.2 Global Remdesivir Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Remdesivir Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Remdesivir Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Remdesivir Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Remdesivir Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Remdesivir Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Remdesivir Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Remdesivir Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Remdesivir Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Remdesivir Revenue by Region
- 7.1 Global Remdesivir Revenue by Region
- 7.1.1 Global Remdesivir Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Remdesivir Revenue by Region (2021-2026)
- 7.1.3 Global Remdesivir Revenue by Region (2027-2032)
- 7.1.4 Global Remdesivir Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Remdesivir Revenue (2021-2032)
- 7.2.2 North America Remdesivir Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Remdesivir Revenue (2021-2032)
- 7.3.2 Europe Remdesivir Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Remdesivir Revenue (2021-2032)
- 7.4.2 Asia-Pacific Remdesivir Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Remdesivir Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Remdesivir Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Kelun Pharma
- 8.1.1 Kelun Pharma Company Information
- 8.1.2 Kelun Pharma Business Overview
- 8.1.3 Kelun Pharma Remdesivir Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Kelun Pharma Remdesivir Product Portfolio
- 8.1.5 Kelun Pharma Recent Developments
- 8.2 Hunan Warrant Pharmaceutical
- 8.2.1 Hunan Warrant Pharmaceutical Company Information
- 8.2.2 Hunan Warrant Pharmaceutical Business Overview
- 8.2.3 Hunan Warrant Pharmaceutical Remdesivir Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Hunan Warrant Pharmaceutical Remdesivir Product Portfolio
- 8.2.5 Hunan Warrant Pharmaceutical Recent Developments
- 8.3 Hainan Haiyao
- 8.3.1 Hainan Haiyao Company Information
- 8.3.2 Hainan Haiyao Business Overview
- 8.3.3 Hainan Haiyao Remdesivir Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Hainan Haiyao Remdesivir Product Portfolio
- 8.3.5 Hainan Haiyao Recent Developments
- 8.4 Bright Gene
- 8.4.1 Bright Gene Company Information
- 8.4.2 Bright Gene Business Overview
- 8.4.3 Bright Gene Remdesivir Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Bright Gene Remdesivir Product Portfolio
- 8.4.5 Bright Gene Recent Developments
- 8.5 Gilead Sciences
- 8.5.1 Gilead Sciences Company Information
- 8.5.2 Gilead Sciences Business Overview
- 8.5.3 Gilead Sciences Remdesivir Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Gilead Sciences Remdesivir Product Portfolio
- 8.5.5 Gilead Sciences Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Remdesivir Value Chain Analysis
- 9.1.1 Remdesivir Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Remdesivir Production Mode & Process
- 9.2 Remdesivir Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Remdesivir Distributors
- 9.2.3 Remdesivir Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst